Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer
Clinical trial NCT04805736 · COMPLETED
Trial details
- NCT number
- NCT04805736
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2023-04-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.